Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Aclaris Therapeutics Shares Outstanding 2014-2019 | ACRS

Aclaris Therapeutics shares outstanding from 2014 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Aclaris Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 33
2017 28
2016 21
2015 6
2014 2
2013 1
Aclaris Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 41
Q2 2019 41
Q1 2019 41
Q4 2018 33
Q3 2018 31
Q2 2018 31
Q1 2018 31
Q4 2017 28
Q3 2017 29
Q2 2017 27
Q1 2017 26
Q4 2016 21
Q3 2016 21
Q2 2016 21
Q1 2016 20
Q4 2015 6
Q3 2015 2
Q2 2015 2
Q1 2015 2
Q4 2014
Q3 2014 2
Q4 2013
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.081B $0.010B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $56.137B 33.58
Astellas Pharma (ALPMY) Japan $33.066B 15.76
Eisai (ESALY) Japan $19.882B 38.34
Merck (MKGAF) Germany $15.419B 21.04
Grifols, S.A (GRFS) Spain $14.796B 18.88
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.201B 481.61
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.999B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.026B 16.26
Sage Therapeutics (SAGE) United States $7.563B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.362B 9.40
Catalent (CTLT) United States $7.245B 29.48
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.320B 19.13
United Therapeutics (UTHR) United States $4.020B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.992B 91.52
FibroGen (FGEN) United States $3.617B 90.48
Nektar Therapeutics (NKTR) United States $3.513B 0.00
Evotec AG (EVTCY) Germany $3.183B 43.58
Taro Pharmaceutical Industries (TARO) Israel $2.962B 10.82
PTC Therapeutics (PTCT) United States $2.538B 0.00
Tilray (TLRY) Canada $2.287B 0.00
Portola Pharmaceuticals (PTLA) United States $2.214B 0.00
Zogenix (ZGNX) United States $1.920B 0.00
Xencor (XNCR) United States $1.887B 57.35
Pacira Pharmaceuticals (PCRX) United States $1.833B 54.35
Ironwood Pharmaceuticals (IRWD) United States $1.728B 55.10
Corcept Therapeutics (CORT) United States $1.715B 20.85
Heron Therapeutics (HRTX) United States $1.714B 0.00
USANA Health Sciences (USNA) United States $1.641B 17.51
Enanta Pharmaceuticals (ENTA) United States $1.250B 20.62
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.147B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.997B 0.00
Endo (ENDP) Ireland $0.982B 1.80
Spectrum Pharmaceuticals (SPPI) United States $0.973B 0.00
ArQule (ARQL) United States $0.925B 0.00
Karyopharm Therapeutics (KPTI) United States $0.924B 0.00
Aerie Pharmaceuticals (AERI) United States $0.891B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.817B 5.57
Dova Pharmaceuticals (DOVA) United States $0.806B 0.00
TherapeuticsMD (TXMD) United States $0.773B 0.00
Organogenesis Holdings (ORGO) United States $0.682B 0.00
Collegium Pharmaceutical (COLL) United States $0.669B 0.00
Flexion Therapeutics (FLXN) United States $0.627B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.563B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.522B 0.00
ImmunoGen (IMGN) United States $0.501B 0.00
Concordia (CXRXF) Canada $0.494B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Siga Technologies (SIGA) United States $0.450B 10.29
Dermira (DERM) United States $0.449B 0.00
OptiNose (OPTN) United States $0.414B 0.00
Recro Pharma (REPH) United States $0.391B 0.00
Indivior (INVVY) United States $0.387B 1.40
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.371B 16.03
Ardelyx (ARDX) United States $0.366B 0.00
DURECT (DRRX) United States $0.365B 0.00
Innate Pharma SA (IPHYF) France $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.19
Molecular Templates (MTEM) United States $0.338B 0.00
Harpoon Therapeutics (HARP) United States $0.320B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.297B 0.00
GlycoMimetics (GLYC) United States $0.271B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.265B 0.00
Rafael Holdings (RFL) United States $0.258B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.186B 0.00
Calithera Biosciences (CALA) United States $0.182B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 31.07
MARKER THERAPEUTICS, INC (MRKR) United States $0.177B 0.00
CV Sciences (CVSI) United States $0.170B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Ocular Therapeutix (OCUL) United States $0.157B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.148B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Aquestive Therapeutics (AQST) United States $0.135B 0.00
Jounce Therapeutics (JNCE) United States $0.135B 1.80
MEI Pharma (MEIP) United States $0.135B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.35
Neos Therapeutics (NEOS) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Generex Biotechnology (GNBT) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Lipocine (LPCN) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.064B 9.67
Adamis Pharmaceuticals (ADMP) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
IntelGenx Technologies (IGXT) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
AgeX Therapeutics (AGE) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
India Globalization Capital (IGC) United States $0.035B 0.00
Mast Therapeutics (SVRA) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Melinta Therapeutics (MLNT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
IsoRay (ISR) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00